Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer

Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy

Inclusion Criteria:

• Female patients with histologically confirmed early-stage breast cancer (T1-2 and N0-1) or ductal carcinoma in situ (DCIS).
• Patients undergoing breast-conserving surgery
• Age ≥ 20 years
• Karnofsky Performance Status (KPS) ≥70%
• Life expectancy ≥ 5 years
• Adequate renal and hepatic function

Exclusion Criteria:

• Pregnant patients
• Patients requiring re-irradiation of the thoracic region